Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
US10596183B2 · kind B2 · utility
2Cited by
4References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 6, 2018 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Sep 6, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are combination therapies for cancer (such as lymphoid malignancies) and immune diseases (such as autoimmune diseases and inflammatory diseases). The therapies comprise the combined use of inhibitors of BTK, mTOR kinase, and Bcl-2 or their signaling pathways, and immunomodulatory drugs. Also described are pharmaceutical compositions and kits comprising these inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.